AMLX250117C00035000 Option on Amylyx Pharmaceuticals
AMLX Etf | USD 3.92 0.23 5.54% |
AMLX250117C00035000 is a PUT option contract on Amylyx Pharmaceuticals' common stock with a strick price of 35.0 expiring on 2025-01-17. The contract was not traded in recent days and, as of today, has 11 days remaining before the expiration. The option is currently trading at a bid price of $1.35, and an ask price of $5.5. The implied volatility as of the 6th of January is 11.0.
Amylyx |
A put option written on Amylyx Pharmaceuticals becomes more valuable as the price of Amylyx Pharmaceuticals drops. Conversely, Amylyx Pharmaceuticals' put option loses its value as Amylyx Etf rises.
Rule 16 of 2025-01-17 Option Contract
The options market is anticipating that Amylyx Pharmaceuticals will have an average daily up or down price movement of about 0.0512% per day over the life of the option. With Amylyx Pharmaceuticals trading at USD 3.92, that is roughly USD 0.002008. If you think that the market is fully understating Amylyx Pharmaceuticals' daily price movement you should consider buying Amylyx Pharmaceuticals options at that current volatility level of 0.82%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Out Of The Money Call Option on Amylyx Pharmaceuticals
An 'Out of The Money' option on Amylyx has a strike price that Amylyx Etf has yet to reach, meaning the option has no intrinsic value. 'Out of The Money' options are usually less costly than 'In The Money' options, making them more desirable to traders with smaller amounts of capital. Some of the uses for Amylyx Pharmaceuticals' 'Out of The Money' options include buying the options if you expect a big move in Amylyx Pharmaceuticals' stock. Since 'Out of The Money' options have a lower up-front cost (i.e., no intrinsic value) than 'In The Money' options, buying it is a reasonable choice.
Call Contract Name | AMLX250117C00035000 |
Expires On | 2025-01-17 |
Days Before Expriration | 11 |
Delta | 0.434487 |
Vega | 0.081089 |
Gamma | 0.023311 |
Theoretical Value | 3.43 |
Open Interest | 31 |
Strike Price | 35.0 |
Current Price Spread | 1.35 | 5.5 |
Rule 16 Daily Up or Down | USD 0.002008 |
Amylyx short PUT Option Greeks
Amylyx Pharmaceuticals' Option Greeks for the contract ending on 2025-01-17 at a strike price of 35.0 measures the various factors that affect its cost and calculated using a theoretical options pricing model. It helps investors make more informed decisions about whether to trade this option contract or when to trade it. In addition to Amylyx Pharmaceuticals' option greeks, its implied volatility helps estimate the risk of Amylyx Pharmaceuticals stock implied by the prices of the options on Amylyx Pharmaceuticals' stock.
Delta | 0.434487 | |
Gamma | 0.023311 | |
Theta | -0.007704 | |
Vega | 0.081089 | |
Rho | 0.057521 |
Amylyx long PUT Option Payoff at expiration
Put options written on Amylyx Pharmaceuticals grant holders of the option the right to sell a specified amount of Amylyx Pharmaceuticals at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Amylyx Etf cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on Amylyx Pharmaceuticals is like buying insurance aginst Amylyx Pharmaceuticals' downside shift.
Profit |
Amylyx Pharmaceuticals Price At Expiration |
Amylyx short PUT Option Payoff at expiration
By selling Amylyx Pharmaceuticals' put option, the investors signal their bearish sentiment. A short position in a put option written on Amylyx Pharmaceuticals will generally make money when the underlying price is above the strike price. Therefore Amylyx Pharmaceuticals' put payoff at expiration depends on where the Amylyx Etf price is relative to the put option strike price. The breakeven price of 38.43 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to Amylyx Pharmaceuticals' price. Finally, at the strike price of 35.0, the payoff chart is constant and positive.
Profit |
Amylyx Pharmaceuticals Price At Expiration |
Amylyx Pharmaceuticals Available Call Options
Amylyx Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Amylyx. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Amylyx. It also shows strike prices and maturity days for a Amylyx Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open Int | Strike Price | Current Spread | Last Price | |||
Call | AMLX250117C00003000 | 0 | 3.0 | 14.2 - 17.5 | 14.2 | |
Call | AMLX250117C00005000 | 0 | 5.0 | 12.7 - 16.0 | 12.7 | |
Call | AMLX250117C00008000 | 0 | 8.0 | 10.6 - 14.5 | 10.6 | |
Call | AMLX250117C00010000 | 0 | 10.0 | 10.1 - 13.5 | 10.1 | |
Call | AMLX250117C00012500 | 1 | 12.5 | 8.9 - 12.0 | 8.9 | Out |
Call | AMLX250117C00015000 | 3 | 15.0 | 7.8 - 11.0 | 7.8 | Out |
Call | AMLX250117C00017500 | 153 | 17.5 | 6.8 - 10.0 | 6.8 | Out |
Call | AMLX250117C00020000 | 18 | 20.0 | 4.8 - 9.0 | 4.8 | Out |
Call | AMLX250117C00022500 | 14 | 22.5 | 4.1 - 8.5 | 4.1 | Out |
Call | AMLX250117C00025000 | 217 | 25.0 | 3.4 - 7.5 | 3.4 | Out |
Call | AMLX250117C00030000 | 36 | 30.0 | 2.25 - 6.5 | 2.25 | Out |
Call | AMLX250117C00035000 | 31 | 35.0 | 1.35 - 5.5 | 1.35 | Out |
Call | AMLX250117C00040000 | 128 | 40.0 | 0.65 - 5.0 | 0.65 | Out |
Call | AMLX250117C00045000 | 5 | 45.0 | 0.05 - 5.0 | 0.05 | Out |
Call | AMLX250117C00050000 | 21 | 50.0 | 1.0 - 4.9 | 1.0 | Out |
Call | AMLX250117C00055000 | 3 | 55.0 | 0.0 - 5.0 | 5.0 | Out |
Call | AMLX250117C00060000 | 4 | 60.0 | 0.0 - 5.0 | 5.0 | Out |
Other Information on Investing in Amylyx Etf
Amylyx Pharmaceuticals financial ratios help investors to determine whether Amylyx Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amylyx with respect to the benefits of owning Amylyx Pharmaceuticals security.